Cutaneous and Gastrointestinal Symptoms in Two Patients with Systemic Mastocytosis Successfully Treated with Omalizumab
The pathogenesis of mastocytosis is not well defined and thus treatment remains challenging and remains on a palliative basis. We present two cases (a 48-year-old woman and a 57-year-old man) with indolent systemic mastocytosis in whom omalizumab (anti-IgE) reduced gastrointestinal and cutaneous sym...
Saved in:
Main Authors: | Sofie Lieberoth, Simon Francis Thomsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2015/903541 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Omalizumab in Indolent Systemic Mastocytosis
by: Calum Slapnicar, et al.
Published: (2019-01-01) -
Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature
by: Misbah Nasheela Ghazanfar, et al.
Published: (2015-01-01) -
A Case of Severe Asthma with Eosinophilic Otitis Media Successfully Treated with Anti-IgE Monoclonal Antibody Omalizumab
by: Azusa Okude, et al.
Published: (2012-01-01) -
Cutaneous sarcoidosis successfully treated with PUVA therapy
by: Agata Szczecina, et al.
Published: (2025-01-01) -
An Adult Patient with Systemic Mastocytosis and B-Acute Lymphoblastic Leukemia
by: Theodoros Iliakis, et al.
Published: (2014-01-01)